<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Palatino;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:739719324;
mso-list-type:hybrid;
mso-list-template-ids:-1475817230 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l1
{mso-list-id:1111167365;
mso-list-template-ids:-490707270;}
@list l1:level1
{mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-weight:bold;
mso-bidi-font-weight:bold;}
@list l1:level2
{mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level3
{mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level4
{mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level5
{mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level6
{mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level7
{mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level8
{mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level9
{mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l2
{mso-list-id:1270698491;
mso-list-template-ids:-1582431222;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3
{mso-list-id:1766684258;
mso-list-template-ids:-1056302166;}
@list l3:level1
{mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-weight:bold;
mso-bidi-font-weight:bold;}
@list l3:level2
{mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level3
{mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level4
{mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level5
{mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level6
{mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level7
{mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level8
{mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l3:level9
{mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://rivkin.org/research/apply/__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-oYflC_U$">Marsha Rivkin Center for Ovarian Cancer: Research Grants</a><o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="color:black;margin-left:0in;mso-list:l0 level1 lfo1">
<b><span style="font-size:12.0pt;font-family:Palatino">Pilot Study Program</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">Two-year awards of total $75,000. Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed
to analyze data from already funded clinical trials will be considered. Funds are for direct costs only.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due December 1, 2020.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: November 16 (due to Fall Break).</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="color:black;margin-left:0in;mso-list:l0 level1 lfo1">
<b><span style="font-size:12.0pt;font-family:Palatino">Scientific Scholar Award</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">Two-year grants at $120,000 each, Scientific Scholar Awards are intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator
in ovarian cancer research. Funds are for direct costs only.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due December 1, 2020.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: November 16 (due to Fall Break).</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="color:black;margin-left:0in;mso-list:l0 level1 lfo1">
<b><span style="font-size:12.0pt;font-family:Palatino">Bridge Funding Award</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The Rivkin Center provides interim funding of up to $30,000 for six months to researchers who have submitted to the National Institutes of Health (NIH) or an original proposal
to the Department of Defense (DoD) pertaining to ovarian cancer and who were not funded but received a score close to the funding threshold. With more data, ovarian cancer researchers stand a better chance of being successfully funded with a stronger, resubmitted
proposal.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due May 1, 2021.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: April 20.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://www.nsf.gov/pubs/2021/nsf21517/nsf21517.htm__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-AiX6Fwo$" target="_blank">NSF: Integrative Strategies for Understanding Neural and Cognitive Systems (NCS)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The complexities of brain and behavior pose fundamental questions in many areas of science and engineering, drawing intense interest across a broad spectrum of disciplinary
perspectives while eluding explanation by any one of them. Rapid advances within and across disciplines are leading to an increasingly interwoven fabric of theories, models, empirical methods and findings, and educational approaches, opening new opportunities
to understand complex aspects of neural and cognitive systems through integrative multidisciplinary approaches. This program calls for innovative, convergent, boundary-crossing proposals that can best capture those opportunities and map out new research frontiers.
NSF seeks proposals that pursue high-value scientific and technical risks by transcending the perspectives and approaches typical of disciplinary research efforts. This cross-directorate program is one element of NSF’s participation in the Brain Research through
Advancing Innovative Neurotechnologies (BRAIN) Initiative (<a href="https://urldefense.com/v3/__https://www.nsf.gov/brain/__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-ATs8Tb0$">https://www.nsf.gov/brain/</a>).<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The program focuses on four aspects of neural and cognitive systems that are current targets of converging interdisciplinary interests. NCS projects must advance the foundations
of one or more of these focus areas, as described further within the solicitation:<o:p></o:p></span></p>
<ol style="margin-top:0in" start="1" type="1">
<li class="MsoNormal" style="color:black;mso-list:l1 level1 lfo2"><b><span style="font-size:12.0pt;font-family:Palatino">Neuroengineering and Brain-Inspired Concepts and Designs</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l1 level1 lfo2"><b><span style="font-size:12.0pt;font-family:Palatino">Individuality and Variation</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l1 level1 lfo2"><b><span style="font-size:12.0pt;font-family:Palatino">Cognitive and Neural Processes in Realistic, Complex Environments</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l1 level1 lfo2"><b><span style="font-size:12.0pt;font-family:Palatino">Data-Intensive Neuroscience and Cognitive Science</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></li></ol>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">Proposals must address both risk and reward:
<b>high-risk, high-payoff approaches are expected</b>. Proposals must also go <b>
beyond the scope of any NSF core program</b>, or they will not be considered responsive to this solicitation.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">NCS will consider two classes of proposals.
<b>FOUNDATIONS</b> awards will support high-risk, high-payoff projects that advance the foundations of one or more NCS focus areas.
<b>FRONTIERS</b> awards (FY2021 and FY2023 competitions only) will support ambitious, highly integrative, interdisciplinary projects that advance and connect multiple integrative research threads to tackle challenges that would be intractable without a high
level of collaboration and coordination. Community-driven efforts such as workshops or synthesis papers are also encouraged, to map out new frontiers at the interface of neuroscience and other disciplines that could reshape brain research and its applications.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">FRONTIERS: Required letter of intent due December 15, 2020. Proposals due January 15, 2021. </span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA
deadline to receive draft documents for letter of intent: December 2. Med-RA deadline to receive draft documents for proposal: January 4.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">FOUNDATIONS: Proposals due January 15, 2021.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: January 4.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-012.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-bZ9Bngk$" target="_blank">Elucidation of mechanisms underlying complex morbidities of SUD and other mental
Illnesses in people living with HIV/AIDS (R01 Clinical Trial Optional)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The purpose of this funding opportunity is to support research that will elucidate neurobehavioral mechanisms underlying multimorbidities involving SUD and co-occurring psychiatric
disorders in people living with HIV.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due January 6, 2021.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: December 14 (due to Winter Break).</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-054.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-3dxAGhU$" target="_blank">Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical
Trial Not Allowed)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">This funding opportunity announcement invites applications to develop and apply innovative synthetic biology approaches to address challenges across the spectrum of cancer
research. Projects will be required to apply a technology, based on an engineered biological system, to an important and well-defined cancer research question. Collaborative transdisciplinary teams are expected, with PIs representing expertise in cancer research,
engineering, and other disciplines relevant to synthetic biology.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due January 15, 2021.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: January 4.<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-21-034.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-qCyNpYg$" target="_blank">NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational
activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary
focus on:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="color:black;mso-list:l2 level1 lfo3"><b><span style="font-size:12.0pt;font-family:Palatino">Courses for Skills Development:
</span></b><span style="font-size:12.0pt;font-family:Palatino">For example, advanced courses in a specific discipline or research area, clinical procedures for research, or specialized research techniques. NIDDK supports skill development for research on diabetes
and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases.<o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l2 level1 lfo3"><b><span style="font-size:12.0pt;font-family:Palatino">Research Experiences:
</span></b><span style="font-size:12.0pt;font-family:Palatino">For example, for undergraduate students: to provide hands-on exposure to research, to reinforce their intent to graduate with a science degree, and/or to prepare them for graduate school admissions
and/or careers in research; for graduate and medical, dental, nursing and other health professional students: to provide research experiences and related training not available through formal NIH training mechanisms; for postdoctorates, medical residents and
faculty: to extend their skills, experiences, and knowledge base in order to engage in research activities. These experiences are expected to be relevant for research within the mission of NIDDK that includes diabetes and other endocrine and metabolic diseases;
digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due January 28, 2021; January 28, 2022; and January 31, 2023.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents for January 2021 due date: January 14.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://www.nsf.gov/pubs/2021/nsf21516/nsf21516.htm__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-P2cWxzg$" target="_blank">NSF: Mid-Career Advancement (MCA)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The MCA offers an opportunity for scientists and engineers at the Associate Professor rank (or equivalent) to substantively enhance and advance their research program through
synergistic and mutually beneficial partnerships, typically at an institution other than their home institution. Projects that envision new insights on existing problems or identify new but related problems previously inaccessible without new methodology or
expertise from other fields are encouraged. Partners from outside the PI’s own sub-discipline or discipline are encouraged, but not required, to enhance interdisciplinary networking and convergence across science and engineering fields. By (re)-investing in
mid-career investigators, NSF aims to enable and grow a more diverse scientific workforce (more women, persons with disabilities, and underrepresented minorities) at high academic ranks, who remain engaged and active in cutting-edge research. Participating
programs in the Directorates for Biological Sciences (BIO), Geosciences (GEO), Engineering (ENG), Social, Behavioral and Economic Sciences (SBE), and Education and Human Resources (EHR) will accept MCA proposals.
<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due February 1, 2021 and February 7, 2022.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents for 2021 due date: January 19.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://www.nsf.gov/pubs/2021/nsf21514/nsf21514.htm__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-_n-BNko$" target="_blank">NSF Human Networks and Data Science</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The Human Networks and Data Science program (HNDS) supports research that enhances understanding of human behavior and how humans interact with and are influenced by their
environments by leveraging data science and network science research across a broad range of topics. HNDS research will identify ways in which dynamic, distributed, and heterogeneous data can provide novel answers to fundamental questions about individual
and group behavior. HNDS is especially interested in proposals that provide data-rich insights about human networks to support improved health, prosperity, and security.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">HNDS has two tracks:<o:p></o:p></span></p>
<ol style="margin-top:0in" start="1" type="1">
<li class="MsoNormal" style="color:black;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;font-family:Palatino">Human Networks and Data Science – Infrastructure (HNDS-I)</span></b><span style="font-size:12.0pt;font-family:Palatino">. Infrastructure
proposals will address the development of data resources and relevant analytic techniques that support fundamental Social, Behavioral and Economic (SBE) research. Successful proposals will, within the financial resources provided by the award, construct user-friendly
large-scale next-generation data resources and relevant analytic techniques and produce a finished product that will enable new types of data-intensive research. The databases or techniques should have significant impacts, either across multiple fields or
within broad disciplinary areas, by enabling new types of data-intensive research in the SBE sciences.<o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l3 level1 lfo4"><b><span style="font-size:12.0pt;font-family:Palatino">Human Networks and Data Science – Core Research (HNDS-R)</span></b><span style="font-size:12.0pt;font-family:Palatino">. Core research proposals
will address theoretically motivated questions about the nature, causes, and/or consequences of human behavior (broadly defined) that occurs within contexts defined by the networks that determine the human experience, from the biological networks in the human
body to the sociocultural, economic and geospatial networks that comprise human societies. HNDS-R proposals should be submitted through any primary disciplinary program within SBE and not to this solicitation. HNDS-R is interested in leveraging multi-scale,
multi-level network data and techniques of network analysis to further theory development across the social sciences. Proposals that address human behavior within complex hierarchical network structures and/or that address problems involving nonlinear dynamics
and network heterogeneity are particularly encouraged. Supported projects are expected to yield results that will enhance, expand, and transform theory and methods, and that generate novel understandings of human networks – particularly understandings that
can improve the outcomes of significant societal opportunities and challenges. HNDS-R encourages core research proposals that make innovative use of NSF-supported data networks, data bases, centers, and other forms of scientific infrastructure including those
developed by HNDS-I (formerly RIDIR) projects.<o:p></o:p></span></li></ol>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due February 4, 2021 and February 2, 2022.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents for 2021 due date: January 25.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-140.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-JrdGy3s$" target="_blank">BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for
Brain Cell Census (R01 Clinical Trial Not Allowed)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">This Funding Opportunity Announcement (FOA) intends to accelerate the use of scalable technologies and tools to enhance brain cell census research, including the development
of technology platforms and/or resources and the generation of spatiotemporal cell census data and/or resources. Applications are expected to address limitations and gaps of existing technologies/tools as a benchmark against which the improvements or competitive
advantages of the proposed ones will be measured. The improvements include throughput, sensitivity, selectivity, scalability, spatiotemporal resolution and reproducibility in cell atlas analyses. The projects funded under this FOA will align with the overarching
goals of the BRAIN Initiative Cell Census Network (BICCN) and are expected to enable the generation of a large amount of cell census data using the proposed technologies or via collaboration with the BICCN.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due March 10, 2021.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: February 25.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-076.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-F_mFPVE$" target="_blank">New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01
Clinical Trial Not Allowed)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The purpose of this Funding Opportunity Announcement is to support research on the development and validation of innovative strategies to deliver anti-HIV gene therapies efficiently
to specific target cells <i>in vivo</i>.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due March 17, 2021; March 17, 2022; and March 17, 2023.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents for 2021 due date: March 4.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 / R01 Clinical Trial Not Allowed)<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/par-21-054.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-X2Wjt7w$" target="_blank">R21</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-21-055.html__;!!PhOWcWs!lLGYeg8VAQZLTA6_8a99dnZG7K8Q8j9znzICgJAKXpWJL9UEgOH14TpBmPDwf_Ji6sHrl_9b2-Y-SiJdl3c$" target="_blank">R01</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">These Funding Opportunity Announcement (FOAs) solicit applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction
with privately or publicly funded, ongoing clinical projects (parent projects). The parent projects can be an interventional clinical trial, or a clinical study such as an observational study that will be actively collecting patient samples or clinical data.
The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. Applications submitted in response to these FOAs will undergo an accelerated review and award process. The objective
of these FOAs is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve
the research community’s understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due March 18, 2021; July 20, 2021; November 18, 2021; March 18, 2022; July 20, 2022; and November 18, 2022.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents for March 2021 due date: March 8.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">To search for additional funding opportunities, please visit <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=" title="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV69">CoM’s
unofficial funding opportunities blog</a>.<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p> </o:p></span></p>
</div>
</body>
</html>